Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alimera Sciences Inc (NQ: ALIM )

4.850 USD -0.010 (-0.21%)
Official Closing Price Updated: 4:00 PM EDT, Oct 1, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,840
Open 4.870
Bid (Size) 3.550 (2)
Ask (Size) 5.120 (27)
Prev. Close 4.860
Today's Range 4.800 - 4.900
52wk Range 0.0003 - 9.980
Shares Outstanding 70,038,411
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Alimera Sciences Announces Multiple Posters and Papers Highlighting the Durability of ILUVIEN® To Be Presented at the EURETINA 2020 Virtual Congress
From GlobeNewswire News Releases
Alimera Sciences Signs Distribution Agreement With Medis Pharmaceutical to Commercialize Iluvien® in Austria and the Czech Republic
Medis will enable immediate access of ILUVIEN to patients in Austria, and will manage reimbursement negotiations for ILUVIEN in the Czech Republic 
From GlobeNewswire News Releases

Performance

YTD
-40.56%
-40.56%
1 Month
-17.94%
-17.94%
3 Month
-15.06%
-15.06%
6 Month
+33.98%
+33.98%
1 Year
+889.80%
+889.80%

More News

Read More
UPDATE -- Alimera Sciences Announces Participation at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference on September 15, 2020
From GlobeNewswire News Releases
Alimera Sciences Announces Participation at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference on September 15, 2020
From GlobeNewswire News Releases
Alimera Sciences Obtains Reimbursement Approval for ILUVIEN® Use in Non-Infectious Posterior Uveitis in Scotland
From GlobeNewswire News Releases
Alimera Sciences Announces Enrollment of First Patient in Landmark NEW DAY Clinical Trial to Evaluate ILUVIEN® as Baseline Therapy for Diabetic Macular Edema
From GlobeNewswire News Releases
Alimera Sciences Announces National Reimbursement Granted for ILUVIEN® in the Netherlands
From GlobeNewswire News Releases
Alimera Sciences to Present at the LD Micro 500 Virtual Conference on September 2, 2020
From GlobeNewswire News Releases
Alimera Sciences Signs Distribution Agreement With Nordic Prime to Expand International Sales of ILUVIEN® Into Nordic Countries
From GlobeNewswire News Releases
Alimera Sciences Inc. (NASDAQ: ALIM) Featured in Virtual Coverage of The LD 500
From InvestorBrandNetwork
Alimera Sciences Announces Second Quarter 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]